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Summary




causes the severe diarrhoeal disease cholera. The two





ing infection are the cholera toxin (CT) and the toxin-
coregulated pilus (TCP). Transcription of the genes
encoding both CT and the components of the TCP is
directly activated by ToxT, a transcription factor in the









gene in a large operon encoding the components of








 that contain ToxT binding sites do not have any
significant similarity other than being AT-rich. Exten-
sive site-directed mutagenesis was performed on the




 previously shown to be pro-
tected by ToxT, and we identified specific base pairs




 transcription by ToxT.
This genetic approach was complemented by copper-
phenanthroline footprinting experiments that showed
protection by ToxT of the base pairs identified as most
important for transcription activation in the mutagen-
esis experiments. Based on this new information and
on previous work, we propose the presence of a ToxT-
binding motif – the ‘toxbox’ – in promoters regulated




, two toxbox elements are present in
a direct repeat configuration and both are required for
activation of transcription by ToxT. The identity of only
a few of the base pairs within the toxbox is important
for activation by ToxT, and we term these the core
toxbox elements. Lastly, we examined ToxT binding to





 and found that occupancy of both bind-
ing sites is retained regardless of the positions of the
binding sites relative to each other on the face of the
DNA. This suggests that ToxT binds independently as





in accordance with what we observed previously with













 secretes cholera toxin (CT), which is
responsible for the clinical aspects of cholera disease. The





toxin-coregulated pilus (TCP), a type IV bundle-forming





















 virulence genes is regulated by a cascade of
transcription factors. The virulence genes are collectively
known as the ToxR regulon for historical purposes,
because ToxR was the first regulator of virulence that was
identified. However, it is ultimately ToxT protein that














ToxT, a 32 kDa, 276-amino-acid protein, is a member of





., 1992). This family shares a domain of approx-
imately 100 amino acids that contains two helix–turn–helix




., 1997; Martin and
Rosner, 2001; Tobes and Ramos, 2002). In ToxT, the
AraC/XylS family domain consists of the 104 C-terminal
amino acids. The remaining 172 N-terminal amino acids
of ToxT, which presumably form a separate N-terminal




searches of the protein database with this region alone





 exhibit significant variation in this
region of ToxT, whereas the C-terminal AraC/XylS region





Common functions for secondary domains among other
AraC/XylS family members include effector binding and
multimerization. ToxT is not known to bind any effectors,
although bile may be a negative regulator of its activity
(Schuhmacher and Klose, 1999). Recently we have found
evidence that ToxT binds independently, most likely as








, which encode components of the accessory coloni-
zation factor (Withey and DiRita, 2005a). ToxT activates








 from this central posi-
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 ToxT binding sites are con-
figured as an inverted repeat separated by 2 bp.








 proposed a consensus DNA binding sequence
for ToxT consisting of a 13 bp site with a tract of T nucle-









 end of the site (Withey and DiRita, 2005a).
Tracts of four or more consecutive T or A mononucleotides
are the only common features found upstream of all genes
known to be activated by ToxT, and T tracts are the only
obvious conserved sequences found among ToxT binding
sites (Withey and DiRita, 2005a,b). Prior work on the role








 located the regions
to which ToxT binds upstream of these genes using
genetic techniques and DNase I footprinting, and found
that both ToxT binding regions contain multiple poly-T
tracts (Hulbert and Taylor, 2002; Yu and DiRita, 2002).
However, little information about specific sequence
requirements for ToxT binding and activation was gleaned
from these studies.
In this report, we investigate in greater detail the DNA

























 deletion, we determined which specific
base pairs within the ToxT-binding region are most impor-




 transcription. These experiments
were complemented by copper-phenanthroline footprint-
ing experiments. We find that ToxT uses two 13 bp binding





scription; we propose that the ToxT binding site be named
the ‘toxbox’. Our results further indicate that the identities
of only a few of the base pairs within each of the 13 bp




 activation. Finally, results
from constructs having 5 bp and 10 bp inserted between
the two ToxT binding sites suggest that ToxT binds inde-




 toxboxes, likely as
monomers. However, appropriate spacing of the bound
ToxT molecules relative to the promoter is critical for tran-
scription activation. These findings are similar to those we













Rough mapping of the ToxT binding sites using double 
point mutations
 
We began our studies of the DNA sequence requirements




 by making pairs of





assessing the ability of ToxT to activate transcription from























(Hulbert and Taylor, 2002; Yu and DiRita, 2002), and this
region was also protected by ToxT in DNase I footprinting
experiments (Yu and DiRita, 2002). The notable features
of the DNA sequence in this region are three tracts of
consecutive A/T nucleotides. We will refer here to these
‘T tracts’ on the template strand instead of the correspond-
ing ‘A tracts’ on the non-template strand for the sake of
consistency with our earlier studies (Withey and DiRita,
2005a,b). Two of the tracts contain seven T nucleotides,
and the third contains six T nucleotides (Figs 1 and 2).
Previous work indicated that mutations to the first
(promoter-proximal) and third (promoter-distal) T tracts





(Hulbert and Taylor, 2002). However, the majority of these
mutations were single base pair deletions, which effec-
tively alter all of the sequence upstream of the mutation
and thus confer little information about specific sequence
requirements.
Twelve constructs having pairs of mutations in the
region protected by ToxT in DNase I footprinting experi-








 required for ToxT-directed transcription. The sequence protected by ToxT in DNase I footprinting 








35 promoter elements are 




 are indicated by arrows below the sequence and designated toxbox1 
and toxbox2, for the promoter-proximal and promoter-distal sites, respectively, above the sequence. The numbering below the binding sites 
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mutant sequences were cloned in plasmid pTL61T, which




 gene downstream from mul-
tiple restriction sites. The ability of ToxT to activate tran-






















 deletion. The double





 transcription were located in the first and









 mutations to these two T tracts caused a reduction










under twofold. Mutations to the second (centre) T tract had





had the largest defect in ToxT-directed transcription within





 transcription. This suggests that the second T tract




, rather than being directly contacted by ToxT.
These results are consistent with those from a previous
study that used a genetic screen to identify mutant




(Hulbert and Taylor, 2002). In that study no mutations
were identified within the second T tract. These results
further suggest that there are two ToxT binding sites




, each containing one T tract, and





. This arrangement is similar to the
ToxT binding sites we identified previously (Withey and








 ToxT binding region. The mutated nucleotides are shown in bold. Only the template strand sequence 










 strains carrying plasmids with the indicated 



















 strains for that construct. A minimum of three separate experiments were performed for each strain, 




 the standard deviation.
 WT  GTCATTTTTTGCTGTGTTTTTTTATTTTTTTAATAA  5740 ±1730  129 ±33.7  44x
-44 GTTATTTTTTGCTGTGTTTTTTTATTTTTTTAATAA  8180 ±1520  141 ±11.0  58x
-45 GTCGTTTTTTGCTGTGTTTTTTTATTTTTTTAATAA  4970 ±1520  122 ± 3.46  41x
-46 GTCACTTTTTGCTGTGTTTTTTTATTTTTTTAATAA  5150 ± 544  135 ±25.0  38x
-47 GTCATCTTTTGCTGTGTTTTTTTATTTTTTTAATAA   962 ±  83.9  147 ±32.5   6.5x
-48 GTCATTCTTTGCTGTGTTTTTTTATTTTTTTAATAA  2180 ± 157  119 ±18.6  18x
-49 GTCATTTCTTGCTGTGTTTTTTTATTTTTTTAATAA  2430 ± 496  126 ±26.0  19x
-50 GTCATTTTCTGCTGTGTTTTTTTATTTTTTTAATAA  4060 ±1270  105 ±16.2  39x
-51 GTCATTTTTCGCTGTGTTTTTTTATTTTTTTAATAA  4340 ± 512  114 ± 8.74  38x
-52 GTCATTTTTTACTGTGTTTTTTTATTTTTTTAATAA  5830 ±1680   98.6 ±14.6  59x
-53 GTCATTTTTTGTTGTGTTTTTTTATTTTTTTAATAA  6640 ±1230 97.4 ±14.9  68x
-54 GTCATTTTTTGCCGTGTTTTTTTATTTTTTTAATAA  3390 ±1220  149 ± 8.19  23x
-55 GTCATTTTTTGCTATGTTTTTTTATTTTTTTAATAA 10400 ±1100  131 ±13.1  79x
-56 GTCATTTTTTGCTGCGTTTTTTTATTTTTTTAATAA  8710 ±2030  131 ±12.7  66x
-57 GTCATTTTTTGCTGTATTTTTTTATTTTTTTAATAA  4340 ±1480  146 ±14.2  30x
-58 GTCATTTTTTGCTGTGCTTTTTTATTTTTTTAATAA  6020 ± 951  111 ±20.8  54x
-59 GTCATTTTTTGCTGTGTCTTTTTATTTTTTTAATAA  3390 ± 707  105 ±16.2  32x
-60 GTCATTTTTTGCTGTGTTCTTTTATTTTTTTAATAA  4290 ±1080  103 ±35.8  42x
-61 GTCATTTTTTGCTGTGTTTCTTTATTTTTTTAATAA  2960 ± 700   82.2 ± 5.56  36x
-62 GTCATTTTTTGCTGTGTTTTCTTATTTTTTTAATAA  5340 ± 926   83.4 ±18.2  64x
-63 GTCATTTTTTGCTGTGTTTTTCTATTTTTTTAATAA  7440 ±1690  119 ±10.6  63x
-64 GTCATTTTTTGCTGTGTTTTTTCATTTTTTTAATAA  9670 ±1500  110 ±14.9  88x
-65 GTCATTTTTTGCTGTGTTTTTTTGTTTTTTTAATAA  2740 ±1050   93.5 ± 5.68  29x
-66 GTCATTTTTTGCTGTGTTTTTTTACTTTTTTAATAA  2560 ± 578  122 ± 5.86  21x
-67 GTCATTTTTTGCTGTGTTTTTTTATCTTTTTAATAA   356 ±  73.0  129 ±35.8   2.8x
-68 GTCATTTTTTGCTGTGTTTTTTTATTCTTTTAATAA  1180 ± 270  112 ± 8.50  11x
-69 GTCATTTTTTGCTGTGTTTTTTTATTTCTTTAATAA  1280 ± 530  109 ± 9.29  12x
-70 GTCATTTTTTGCTGTGTTTTTTTATTTTCTTAATAA  4050 ±1140  111 ± 8.19  36x
-71 GTCATTTTTTGCTGTGTTTTTTTATTTTTCTAATAA  4610 ±1300   91.8 ±30.6  50x
-72 GTCATTTTTTGCTGTGTTTTTTTATTTTTTCAATAA   965 ± 261  106 ±16.8   9.1x
-73 GTCATTTTTTGCTGTGTTTTTTTATTTTTTTGATAA  5400 ±1320  112 ± 7.37  48x
-74 GTCATTTTTTGCTGTGTTTTTTTATTTTTTTAGTAA  1430 ± 560  113 ± 4.62  13x
-75 GTCATTTTTTGCTGTGTTTTTTTATTTTTTTAACAA  5590 ±1430  114 ±17.1  49x
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, both T tracts are located on the same DNA




 ToxT binding sites are in
a direct repeat configuration, in contrast to the ToxT bind-














 (Withey and DiRita, 2005b), or the single






Mutagenesis of the entire ToxT-binding region upstream 
of tcpA
To gain further insight into the DNA sequence require-
ments for ToxT-directed transcription of tcpA, we con-
structed a plasmid collection of single base pair tcpA::lacZ
mutants encompassing the entire region between −44 and
−76 relative to the start of tcpA transcription. As shown in
Fig. 2, all of the mutations changed an A/T base pair to a
G/C base pair or vice versa. β-Galactosidase levels were
measured in V. cholerae carrying these plasmids and hav-
ing either wild-type toxT or a toxT deletion (Fig. 2). The β-
galactosidase results from the strains having wild-type
toxT are shown graphically in Fig. 3 above each nucle-
otide. It is evident from these experiments that only a
small number of single base pair mutations significantly
affect the ability of ToxT to activate tcpA transcription.
Calculations of statistical significance by Student’s t-test,
in this case meaning P < 0.03, indicated that mutations at
10 positions caused a significant loss of activation by ToxT
(asterisks in Fig. 3). Mutations to the first and third T tracts
at positions −47 to −49 and −67 to −69 dramatically
reduced the ability of ToxT to activate tcpA transcription.
Mutations to positions −72 and −74 also severely reduced
ToxT-directed tcpA transcription. Mutations to positions
−65 and −66 caused a significant decrease in ToxT-
directed tcpA transcription. For all of the above mutations
P < 0.015. Mutations within the second T tract had little to
no effect on ToxT-directed tcpA transcription with the
exception of positions −59 and −61; these mutations
caused a moderate decrease in ToxT-directed tcpA tran-
scription, although only the β-galactosidase levels from
the −61 mutation are outside of the margin of error, and
then only slightly. P-values for positions −59 and −61 were
0.058 and 0.031 respectively. Finally, mutation to position
−54 produced a decrease in ToxT-directed transcription
similar to those produced by the mutations to positions
−59 and −61, but again this decrease was within the
margin of error and a double mutation of positions −54
and −55 was not at all reduced for ToxT-directed transcrip-
tion (Fig. S1), suggesting that the identity of position −54
has little effect on activation by ToxT; for this mutation,
P = 0.068.
These results, together with our studies of other ToxT
binding sites (Withey and DiRita, 2005a,b), which indi-
cated that ToxT binds to a 13 bp site and that all ToxT
binding sites contain a conserved T tract near the 5′
end, suggest that ToxT binds to two sites in a direct
repeat configuration upstream of tcpA. However, there is
a clear difference between the two binding sites in terms
of the sequence requirements for activation of tcpA by
ToxT. Both the promoter-proximal and promoter-distal
sites, which we will refer to as the toxbox1 and toxbox2
sites, respectively, share a requirement for three con-
secutive T nucleotides at positions 4–6 from the 5′ end
of the binding sites, whereas toxbox2 has additional
sequence requirements at positions 2, 3, 9 and 11
(Figs 1 and 3).
Copper-phenanthroline footprinting of ToxT on the tcpA 
promoter region
Previously, DNase I footprinting was used to localize the
region of ToxT binding upstream of tcpA (Yu and DiRita,










































Fig. 3. Graphical representation of the β-galac-
tosidase results from tcpA::lacZ constructs hav-
ing double point mutations. Results from strains 
having the wild-type (WT) tcpA::lacZ fusion are 
shown at both sides of the figure, and the grey 
box across the figure indicates the standard 
deviation from the mean for the wild-type 
tcpA::lacZ fusion. The values shown are only 
those measured in wild-type ToxT V. cholerae. 
Bars are located over the respective nucleotide 
that is mutated in each construct. Asterisks 
indicate positions to which mutation caused 
a statistically significant decrease in β-
galactosidase levels according to Student’s 
t-test (P < 0.03).
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Fig. 4. Copper-phenanthroline footprints of 
ToxT on tcpA. ToxT binding sites toxbox1 and 
toxbox2 are indicated by arrows. The black bars 
denote the locations of the core toxbox deter-
minants. Numbers refer to positions relative to 
the start of tcpA transcription. F = free DNA, B 
= ToxT/DNA complex. Heavy arrows indicate 
the positions of a hypersensitive site found only 
on the template strand.
A. Non-template strand. The letters ‘A, T, C’ 
above the left side of the figure refer to the 
respective lanes of the sequencing ladder.
B. Template strand. The letters ‘G, A, T, C’ 
above the left side of the figure refer to the 
respective lanes of the sequencing ladder.
at tcpA, here we have instead used copper-1,10-
phenanthroline as the DNA cleavage agent for footprint-
ing. This technique has higher resolution as copper-
1,10-phenanthroline has much less sequence cleavage
specificity than DNase I and cleaves at essentially every
nucleotide (Papavassiliou, 1994; Withey and DiRita,
2005a,b). Purified ToxT bearing six histidine residues at
its N-terminus (H6-ToxT) was used in the footprinting
experiments; previous work demonstrated that H6-ToxT is
functional both in vivo and in vitro for transcription activa-
tion (Yu and DiRita, 2002; Withey and DiRita, 2005a,b).
Copper-phenanthroline footprinting of H6-ToxT on wild-
type tcpA DNA exhibited protection, as expected, within
the two T tracts shown to be essential for ToxT-directed
tcpA transcription (Fig. 4A and B). Some protection was
also conferred by H6-ToxT to the surrounding base pairs
that encompass the ToxT binding sites, especially
toxbox2. However, no significant protection was conferred
by H6-ToxT to nucleotides 9–13 of toxbox1. These results
are consistent with the results described above indicating
the specific sequence requirements for activation of tcpA
by ToxT, and with the sequence differences observed
between the toxbox1 and toxbox2 sites. As predicted,
much less protection was observed between the two ToxT
binding sites, again suggesting that the central T tract
does not play a direct role in ToxT binding and supporting
our designated location for the two ToxT binding sites. In
Fig. 4B (template strand) the band intensity throughout
the bound complex lane is somewhat lower than in the
free DNA lane; however, there is still significant protection
evident within the areas of the binding sites. Furthermore,
there is a difference in protection when comparing toxbox2
in the template (Fig. 4B) versus the non-template (Fig. 4A)
strands; there is an unprotected or even hypersensitive
area present at positions 7 and 8 (Fig. 1) of toxbox2 in the
template strand footprint that is not present in the non-
template strand footprint (heavy arrows in Fig. 4A and B).
However, this lack of protection is consistent with our
finding that mutations at these positions do not affect
activation of tcpA by ToxT, and suggests that ToxT may
bend the DNA at this position.
Alteration of the spacing between the ToxT binding sites 
at tcpA
Our previous work has indicated that ToxT activates
transcription of acfA, acfD and tagA using binding sites
in inverted repeat configurations (Withey and DiRita,
2005a,b), and that only a single ToxT site exists upstream
of aldA (Withey and DiRita, 2005b). Furthermore, we
found evidence that ToxT binds as independent mono-
mers to its two sites between acfA and acfD and that
appropriate spacing between the binding sites is impor-
tant for activation of both genes by ToxT (Withey and
DiRita, 2005a). Because the experiments described here
suggest that ToxT activates transcription of tcpA from two
binding sites in a direct repeat configuration, in contrast
to our previous studies of other genes within the ToxT
regulon, we investigated whether ToxT would activate
tcpA transcription if 5 bp or 10 bp were inserted between
its two binding sites. This is especially germane given the
recent finding that the NTD of ToxT may have dimerization
activity (Prouty et al., 2005). The 5 bp insertion would
rotate toxbox1 and toxbox2 approximately one half-turn of
the DNA helix relative to each other, which would almost
certainly disrupt any interactions between ToxT molecules
1784 J. H. Withey and V. J. DiRita
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bound to the two sites, and the 10 bp insertion would
rotate toxbox1 and toxbox2 approximately one full turn of
the DNA helix relative to each other. The insertions could
also affect potential interactions between ToxT bound to
toxbox2 and the C-terminal domain of the α-subunit of
RNA polymerase (RNAP) (α-CTD); previous work indi-
cated that ToxT most likely interacts with the α-CTD (Hul-
bert and Taylor, 2002).
We assessed the ability of ToxT to activate transcription
from the abnormally spaced binding sites using tcpA::lacZ
fusions as described earlier. As shown in  Table 1, both
the 5 bp and 10 bp insertions between toxbox1 and
toxbox2 completely abrogate activation of tcpA by ToxT.
For the 5 bp insertion, the loss of activation could be due
to either the lack of a necessary interaction between ToxT
molecules, resulting in a loss of DNA binding by ToxT, or
to loss of an interaction between ToxT bound to toxbox2,
which is now on the opposite face of the DNA relative to
the promoter, and α-CTD. To distinguish between the two
possibilities, we used copper-phenanthroline footprinting
to determine the occupancy by H6-ToxT of toxbox1 and
toxbox2 sites having the 5 bp spacing mutation. As shown
in  Fig. 5, both ToxT binding sites are protected regardless
of the 5 bp insertion between them, suggesting that ToxT
binds independently to the toxbox1 and toxbox2 sites, and
that loss of interaction between ToxT bound to toxbox2
and the α-CTD is responsible for the defect in transcription
activation conferred by the 5 bp insertion.
Discussion
In this report we present experiments designed to identify
specific DNA sequence requirements for transcription
activation of the tcpA operon by ToxT. The tcpA operon
includes the genes encoding components of the TCP and
the toxT gene itself, among others, and is critical for
V. cholerae virulence. We examined the effects of single
and double point mutations on the ability of ToxT to acti-
vate tcpA transcription by constructing a collection of
tcpA::lacZ fusions. Each fusion contained the region
upstream of tcpA previously shown to be important for
ToxT function (Hulbert and Taylor, 2002; Yu and DiRita,
2002). These plasmid-based fusions allowed us to test a
large number of mutations; however, it is formally possi-
ble that there are differences in the requirements for ToxT
to activate transcription of plasmid-based constructs and
the requirements for activation on the V. cholerae
chromosome.
The experimental results from tcpA::lacZ constructs
having double point mutations gave us an indication of the
general DNA segments that are important for ToxT-
directed transcription of tcpA. Double mutations to two
of the three T tracts in the tcpA promoter region, the
promoter-proximal (tract 1) and promoter-distal (tract 3) T
tracts, abrogated activation by ToxT. This finding is con-
sistent with the presence of two ToxT binding sites, each
of which contains one of the outer T tracts. The two bind-
ing sites are similar in sequence to those we have identi-
fied previously at other genes within the ToxT regulon
(Fig. 6A) (Withey and DiRita, 2005a,b). The significant
difference between the tcpA ToxT binding sites and the
others we previously identified is that at tcpA the sites are
configured as a direct repeat. Some other genes within
the ToxT regulon also use toxboxes configured as a direct
repeat. Our assignment of the binding sites at ctxAB
(Fig. 6B) is based on data from the study by Yu and DiRita
(2002); because of the T tract repeats in this sequence,
we speculate that ToxT binds a direct repeat here as well.
We also have evidence that ToxT activates two separate
promoters at tcpI (Fig. 6A and B); one of these promoters,
PtcpI-1, has toxboxes configured as an inverted repeat and







tcpA wild-type 5740 ± 1730  120 ± 35.5 48×
tcpA +5 92 ± 10.4 83.3 ± 1.47 1.1×
tcpA +10  86.4 ± 9.83 88.9 ± 9.76 0.97×
Fig. 5. Copper-phenanthroline footprinting of ToxT on DNA having a 
5 bp insertion between the toxbox1 and toxbox2 sites. The results 
using wild-type tcpA DNA are shown at the left of the figure and the 
results using tcpA with a 5 bp insertion between the ToxT binding 
sites are shown at the right of the figure. Toxbox1 and toxbox2 are 
indicated by arrows. F = free DNA, B = ToxT/DNA complex. The 
brackets and ‘+5’ indicate the position of the 5 bp insertion described 
in the text. The letters ‘G, A, T’ refer to the respective lanes of the 
sequencing ladder in the centre of the figure.
F   B               F   B
+5bp
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the other, PtcpI-2, has toxboxes configured as a direct
repeat (J.H. Withey and V.J. DiRita, in preparation).
Double mutations to the central T tract (tract 2) caused
a reduction but not an abrogation of tcpA activation by
ToxT. Because A tracts are known to cause narrowing of
the DNA minor groove and a curvature or kink in the DNA
structure (Wing et al., 1980; Burkhoff and Tullius, 1987;
Haran and Crothers, 1989), it is plausible that the A tract
corresponding to T tract 2 has a structural role in activation
of tcpA by ToxT by permitting enhanced contact between
the ToxT molecule bound to the promoter-distal binding
site and RNAP. Another possibility would be that this cen-
tral A tract increases interaction between ToxT monomers
bound to the two sites, again by bending DNA. A recent
report suggests that ToxT may dimerize or that monomers
may interact at tcpA (Prouty et al., 2005). We present
evidence here and elsewhere (Withey and DiRita, 2005a)
that ToxT likely binds to DNA as a monomer even when
multiple binding sites are required for its function as an
activator. However, interactions between ToxT monomers
after DNA binding may be required for activation of tcpA
transcription; this would be one explanation for our obser-
vation that the 5 bp and 10 bp insertions between the two
ToxT sites abrogate activation of tcpA transcription by
ToxT (Fig. 5).
The experimental results from tcpA::lacZ constructs
having single point mutations gave us the first clear
indication of what specific sequences are required for
activation of tcpA transcription by ToxT. We identified
three consecutive T nucleotides within both toxbox1 and
toxbox2 that are required for significant ToxT-directed tran-
scription of tcpA. These three T nucleotides are at the
same relative positions of both toxbox1 and toxbox2, i.e.
nucleotides 4–6 (Figs 1 and 6A). Mutations to other posi-
tions within toxbox1 did not cause significant defects in
activation by ToxT. However, mutations to positions 9 and
11 of toxbox2 caused dramatic defects in activation by
ToxT, and mutations to positions 2 and 3 of toxbox2
caused significant defects in activation by ToxT. There are
two notable observations based on this information: (i) the
ToxT binding site is degenerate; at most the identities of
seven of 13 bp are important for ToxT function and (ii)
comparison of the toxbox1 and toxbox2 sites indicates a
difference in ToxT requirements; the toxbox1 site has
three nucleotides at which mutations cause significant
defects in activation by ToxT, whereas the toxbox2 site has
seven nucleotides at which mutations cause significant
defects in activation by ToxT. The differences in sequence
translate directly to differences in protection in footprinting
experiments with tcpA promoter DNA; toxbox2 is pro-
Fig. 6. Comparison of ToxT binding site sequences and arrangements among ToxT regulon genes.
A. Alignment of ToxT binding sites. The gene names are at the left of the figure, and the toxbox sequences located upstream of each gene are 
at the right. The solid boxes indicate the core toxbox determinants. The consensus toxbox sequence is shown at the bottom of the figure, as is 
the numbering of the toxbox positions described in the text. In the consensus toxbox sequence, ‘r’ indicates that the nucleotide can be either A 
or G, ‘w’ indicates that the nucleotide can be either A or T and ‘y’ indicates that the nucleotide can be either C or T.
B. Arrangements of toxboxes upstream of ToxT regulon genes. The core promoter −10 and −35 elements are indicated by boxes. Toxboxes are 
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tected along its entire length, including critical positions
2–6, 9 and 11, whereas toxbox1 is protected only in the
region of the T tract (Fig. 4A and B). Similar differences
in copper-phenanthroline footprinting were also observed
for other toxboxes (Withey and DiRita, 2005a,b). This sug-
gests ToxT is making specific contacts with the DNA at
the seven critical base pairs of the toxbox, as defined by
the mutations to toxbox2, and that altering the DNA
sequence removes the specific interaction and thus the
protection conferred by ToxT in copper-phenanthroline
footprinting experiments. In support of this hypothesis,
mutations to the acfA and acfD toxboxes that cause a loss
in transcription activation by ToxT also cause a reduction
in ToxT protection to base pairs in close proximity to the
mutations, although DNA binding by ToxT is retained
(Withey and DiRita, 2005a).
The results from constructs having single point muta-
tions and constructs having double point mutations are
consistent with regard to which base pairs are required
for ToxT to activate transcription; mutations to any of the
base pairs shown to be most important for ToxT-directed
tcpA transcription in Figs 2 and 3 also caused severe
defects in activation by ToxT when a second base pair was
also mutated. Neither single nor double point mutations
to positions 7–13 of toxbox1 caused defects in activation
by ToxT. All of the single base pair mutations described in
this report change A/T base pairs to G/C base pairs; this
was done to maximize the effects of a single mutation in
an effort to determine which base pairs are most critical
for ToxT function. It is possible that changing an A/T base
pair to T/A would have a lesser effect on activation by
ToxT.
Based on this new information about sequence require-
ments for DNA binding and activation by ToxT, we propose
that the ToxT binding site be termed the ‘toxbox’, in accor-
dance with the nomenclature for other AraC family pro-
teins such as MarA (marbox) and SoxS (soxbox) that bind
to degenerate DNA sequences (Martin et al., 1999; Dangi
et al., 2001; Griffith and Wolf, 2001; Martin and Rosner,
2001). Comparison of the toxboxes found at tcpA with
those we have identified at other ToxT-activated genes
(Withey and DiRita, 2005a,b) suggests that the sequence
requirements are similar at all toxboxes, particularly at
those positions that we found were critical for activation
of tcpA by ToxT (Fig. 6A). We refer to the seven critical
nucleotides at positions 2–6, 9 and 11 of the toxbox, as
indicated by the toxbox2 mutations, as the core toxbox
determinants.
The Escherichia coli MarA, SoxS, and Rob proteins are
all about 50% identical in amino acid sequence, bind to
DNA and activate transcription as monomers, and recog-
nize the same degenerate 20 bp sequence (Martin et al.,
1999; Griffith and Wolf, 2001). Because a large number
of sequences consistent with the marbox consensus
sequence are found within the E. coli chromosome, if spe-
cific recognition of the marbox sequence were the only
means of determining MarA, SoxS, or Rob binding, these
proteins would rarely find binding sites at the appropriate
positions relative to a promoter, and would be swamped
by potential binding sites on the chromosome. Instead it
has been proposed that complexes are formed between
the activator proteins and RNAP prior to DNA binding, and
that the activator/RNAP complexes then search for acti-
vator binding sites adjacent to promoters; this is referred
to as ‘prerecruitment’ (Griffith et al., 2002) or ‘DNA scan-
ning’ (Martin et al., 2002). It is quite possible that ToxT
uses a similar mechanism to identify its appropriate
binding sites, as it would be similarly confronted with
abundant sequences similar to actual toxboxes within the
V. cholerae chromosome.
All of the known genes within the ToxT regulon have
toxboxes located upstream of the −35 box, suggesting that
each gene has a class I promoter (Fig. 6B) and thus ToxT
most likely interacts with the RNAP α-CTD (Busby and
Ebright, 1994). Our observations that ToxT activates tran-
scription of various promoters using several different
toxbox configurations suggests that there is significant
flexibility in the putative interactions between ToxT and α-
CTD. We propose here that the architecture of ToxT-acti-
vated promoters with regard to ToxT and α-CTD differs
depending on the configuration of toxboxes relative to the
promoter  (Fig. 7). At promoters having two toxboxes, the
promoter-proximal toxbox is always in the same orienta-
tion relative to the promoter (Fig. 6B). Thus, interactions
between ToxT bound at this position and one α-CTD
would be the same regardless of the orientation of the
promoter-distal toxbox (Fig. 7). The position of the other
α-CTD would differ depending on whether toxboxes are
configured as a direct or inverted repeat. In the case of
aldA, which has only one toxbox that is oriented differently
than other promoter-proximal toxboxes, the interaction
between ToxT and α-CTD would resemble that of the
promoter-distal toxbox in an inverted repeat (Fig. 7).
Previous studies on ToxT activation of acfA and acfD
addressed the question of whether ToxT acts as two
monomers or a dimer to activate transcription of those
genes (Withey and DiRita, 2005a). Numerous AraC/XylS
family members bind DNA either as monomers (Martin
et al., 1999; Griffith and Wolf, 2001; Ibarra et al., 2003) or
as dimers (Egan and Schleif, 1994; Schleif, 2000). Foot-
printing experiments using mutant DNA with 5 bp or 10 bp
insertions between the ToxT binding sites, which would
rotate the binding sites approximately one half-turn or one
full turn of the DNA helix relative to each other, respec-
tively, showed that ToxT protects sites with altered spacing
in a manner indistinguishable from the protection con-
ferred to sites having wild-type spacing. This strongly sug-
gests that the individual toxboxes between acfA and acfD
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do not represent half sites of a larger ToxT binding site,
as each toxbox can be bound independently, presumably
by a ToxT monomer. The arrangement of toxboxes in the
tcpA promoter region is different (direct repeat) than in the
acfA-acfD intergenic region (inverted repeat), so it is pos-
sible that ToxT dimerization is required for DNA binding
and transcription activation of tcpA. Our results here from
a similar copper-phenanthroline footprinting experiment in
which 5 bp was inserted between the tcpA toxboxes indi-
cated that both of the tcpA toxboxes were protected by
ToxT regardless of their position relative to each other,
again suggesting that single toxboxes may be bound by
ToxT monomers. We did, however, observe some protec-
tion in the region between toxbox1 and toxbox2 having the
5 bp insert; the reasons for this are unclear.
The 5 bp and 10 bp insertions between toxbox1 and
toxbox2 both abrogated activation of tcpA by ToxT.
Because the 5 bp insertion would rotate toxbox2 one half-
turn of the DNA away from the core promoter, it is likely
that the loss of activation with this construct is due to the
inability of ToxT bound to toxbox2 to interact productively
with RNAP (Fig. 7). The 10 bp insertion would rotate the
toxboxes approximately one full turn of the DNA relative
to each other and could restore the ability of the α-CTD
to contact the distal ToxT; the observation that this inser-
tion abrogates transcription suggests that the spacing of
the binding sites relative to each other, relative to the
promoter, or both is important, or that this insertion alters
the local DNA structure. The 10 bp insertion does disrupt
the central T tract, and thus likely prevents the DNA bend
that may normally be found there. We have further
observed that the 5 bp and 10 bp insertions between the
−35 promoter element and the promoter-proximal toxbox
at acfA also abrogate activation by ToxT (J.H. Withey and
V.J. DiRita, unpubl. data), further suggesting that proper
spacing of the toxboxes relative to the promoter is impor-
tant for activation by ToxT. Another possibility is that ToxT
monomers interact with each other subsequent to DNA
binding and that this interaction is necessary for transcrip-
tion activation of tcpA by ToxT; this idea is consistent with
recent work that showed dimerization activity in the ToxT
NTD (Prouty et al., 2005). A final possibility is that ToxT
dimers are binding at each toxbox but that no protection
is conferred by half of each ToxT dimer. However, we think
it unlikely that a single ToxT dimer binds to a single pair
of toxboxes given the variety in toxbox configuration and
orientation observed at different promoters. Future work
will address the position, orientations and interactions of
ToxT and RNAP α-CTD at various promoters and test the
models that we have proposed in Fig. 7.
In summary, we have identified specific sequence
requirements for ToxT to activate transcription of the
V. cholerae tcpA operon. The ToxT DNA binding sites, or
toxboxes, have a degenerate sequence within which the
identity of only a few base pairs, the core toxbox determi-
nants, is important. Accordingly, there is considerable
conservation of sequence of these core determinants
among all known ToxT binding sites. ToxT uses two tox-
boxes in a direct repeat configuration to activate transcrip-
tion of tcpA and likely binds to each toxbox as a monomer.
This configuration differs from the ToxT binding site con-
figurations that we have described previously at other
genes; in these cases inverted repeat or single binding
sites are found. ToxT thus is extremely flexible in terms of
both the sequences to which it binds and the configura-
tions of binding sites from which it activates transcription.
Experimental procedures
Bacterial strains and plasmids
All strains used in this study are derivatives of O395 (wild-
type toxT, DiRita lab collection) or VJ740 (∆toxT, Champion
et al., 1997) carrying tcpA::lacZ fusions on plasmid pTL61T
(Linn and St Pierre, 1990). Strains were grown at 37°C in
Luria broth (LB) medium for overnight cultures, and at 30°C
in LB adjusted to a starting pH of 6.5 (inducing conditions)
for use in β-galactosidase assays. Strains were maintained
at −70°C in LB + 20% glycerol. Antibiotics were used at the
following concentrations: ampicillin, 100 µg ml−1; streptomy-
Fig. 7. Models for promoter architecture at genes having different 
toxbox configurations. The stippled ovals indicate ToxT, the white 
circles indicate the RNAP α-CTD, the dark ovals indicate the rest of 
RNAP, the −10 and −35 promoter elements are indicated by boxes 
and labelled, and arrows indicate toxbox positions and orientations.
A. Architecture at a promoter having two toxboxes in an inverted 
repeat configuration (acfA, acfD, tagA, tcpI-1).
B. Architecture at a promoter having two toxboxes in a direct repeat 
configuration (tcpA, tcpI-2, ctxAB).
C. Architecture at a promoter having one toxbox (aldA).
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cin, 100 µg ml−1. Plasmids were introduced into V. cholerae
strains by electroporation using a Bio-Rad E. coli Pulser.
DNA manipulations
Plasmids were purified using the Qiagen Spin Miniprep or
Plasmid Midi kits. Polymerase chain reaction (PCR) was per-
formed using Taq DNA polymerase from Roche as specified
by the manufacturer. Restriction enzymes were purchased
from New England Biolabs and used as specified by the
manufacturer.
Plasmid construction
The wild-type tcpA::lacZ fusion was constructed by PCR of
the appropriate region using fresh O395 colonies as tem-
plate. Site-directed mutations were created using the splicing
by overlap extension technique (SOE) (Horton et al., 1989;
Horton et al., 1993), after which inserts having the desired
mutations were cloned between the XbaI and HindIII sites
of pTL61T (Linn and St Pierre, 1990). The nucleotide
sequences of all plasmid constructs were confirmed by DNA
sequencing at the University of Michigan Sequencing Core.
β-Galactosidase assays
For β-galactosidase assays, V. cholerae strains were grown
overnight at 37°C, subcultured at a 1:40 dilution into fresh
LB, pH 6.5, and grown for 3 h at 30°C. Bacteria were then
placed on ice and chloramphenicol was added to 0.5 mg
ml−1. Assays were performed according to the method of
Miller (Miller, 1972).
Copper-phenanthroline footprinting
Electrophoretic mobility shift assay (EMSA) was performed
as previously described (Withey and DiRita, 2005a). The
amount of H6-ToxT used was determined empirically to be
the amount required to shift approximately 50% of the
labelled DNA. Identical amounts of H6-ToxT were added to
both wild-type DNA probes and DNA probes having +5 bp
insertions as detailed in the text, and both produced similar
amounts of bound product. Plasmids used in the β-galactosi-
dase assays were used as PCR templates as indicated in the
text. After EMSA, the procedure used was that of Papavas-
siliou (Papavassiliou, 1994). Briefly, the gel was soaked in
200 ml 10 mM Tris-HCl, pH 8 in a glass tray. One millilitre of
40 mM 1,10-Phenanthroline (Sigma) was mixed with 1 ml
9 mM CuSO4 (Sigma) for 1 ml, then diluted with 18 ml dH2O.
This was added to the gel tray and mixed by shaking. A 20 ml
aliquot of a 1:200 dilution of 3-Mercaptopropionic acid
(Sigma) was then added to the gel tray and briefly mixed. The
reaction continued for 7 min, and was stopped by addition of
20 ml 28 mM Neocuproine (Sigma), followed by shaking for
2 min. The gel was rinsed with 1000 ml dH2O and placed on
X-ray film for 3 h. After the film was developed, bands corre-
sponding to free DNA and H6-ToxT/DNA complexes were
excised from the gel based on their location in the film, and
the gel slices were crushed and the DNA eluted overnight in
0.5 ml 0.5 M Ammonium Acetate, pH 7.5, 1 mM EDTA, 0.1%
SDS, 10 mM MgCl2. Gel pieces were pelleted by centrifuga-
tion, and the supernatant was passed through a 0.2 µm
syringe filter and ethanol precipitated. The pellets were
resuspended in a 1:1 mixture of TE : sequencing stop solu-
tion (USB) and radioactivity was measured with a Geiger
counter. Approximately equal amounts of labelled DNA from
the free DNA and H6-ToxT/DNA complex bands were loaded
on the subsequent sequencing gel. The sequencing ladder
was produced with a Thermo Sequenase Radiolabeled Ter-
minator Cycle Sequencing Kit (USB) as specified by the
manufacturer, and the sequencing gel was prepared and run
as specified by the sequencing kit manual. The same plasmid
template and the primer that was end-labelled in the EMSA/
footprinting experiment were used in the sequencing reac-
tions. Autoradiography was performed with the resulting gel,
and typical exposure times were 10–14 days.
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Supplementary material
The following supplementary material is available for this
article online:
Fig. S1. Double point mutations to the tcpA ToxT binding
region. The mutated nucleotides are shown in bold. Only the
template strand sequence (lower strand in Fig. 1) is shown.
The results of β-galactosidase assays in wild-type and ∆toxT
strains carrying plasmids with the indicated mutations
upstream of the tcpA::lacZ fusion are shown to the right of
the sequences. ‘Activation’ indicates the fold-difference in β-
galactosidase activity between the wild-type toxT and ∆toxT
strains for that construct. A minimum of three separate exper-
iments were performed for each strain, and the values shown
are the mean ± the standard deviation.
This material is available as part of the online article from
http://www.blackwell-synergy.com
